Endocyte Inc (ECYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,153 | -41,270 | -31,476 | -21,474 | -10,870 |
| Depreciation Amortization | 413 | 2,197 | 1,694 | 1,157 | 562 |
| Accounts receivable | 9 | 856 | 827 | 723 | 719 |
| Accounts payable and accrued liabilities | -546 | -61 | -421 | 171 | 204 |
| Other Working Capital | -2,481 | -128 | -1,313 | -1,228 | -1,414 |
| Other Operating Activity | 2,622 | 6,187 | 4,823 | 2,642 | 759 |
| Operating Cash Flow | $-10,136 | $-32,218 | $-25,866 | $-18,010 | $-10,040 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36 | -342 | -256 | -95 | -45 |
| Purchase Of Investment | -41,853 | -86,282 | -51,747 | -34,703 | -33,114 |
| Sale Of Investment | 76,765 | 88,114 | 62,899 | 34,866 | 26,662 |
| Investing Cash Flow | $34,877 | $1,491 | $10,897 | $68 | $-6,496 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 94 | 684 | 510 | 503 | 299 |
| Common Stock Repurchased | -109 | -57 | -57 | -57 | -57 |
| Financing Cash Flow | $-15 | $627 | $453 | $446 | $241 |
| Exchange Rate Effect | N/A | -1 | -1 | -1 | 0 |
| Beginning Cash Position | 15,432 | 45,533 | 45,533 | 45,533 | 45,533 |
| End Cash Position | 40,157 | 15,432 | 31,015 | 28,036 | 29,239 |
| Net Cash Flow | $24,725 | $-30,102 | $-14,518 | $-17,498 | $-16,295 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,136 | -32,218 | -25,866 | -18,010 | -10,040 |
| Capital Expenditure | -36 | -342 | -256 | -95 | -45 |
| Free Cash Flow | -10,172 | -32,560 | -26,122 | -18,105 | -10,085 |